StockStory.org on MSN
COLL Q3 Deep Dive: Jornay PM Momentum and Pain Portfolio Drive Upgraded Outlook
Pharmaceutical company Collegium Pharmaceutical (NASDAQ:COLL) in Q3 CY2025, with sales up 31.4% year on year to $209.4 million. The company’s full-year revenue guidance of $780 million at the midpoint ...
Expedia stock (NASDAQ: EXPE) third-quarter results didn’t just surprise investors — they reignited confidence in the travel ...
Zacks Investment Research on MSN
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...
JPMorgan U.S. Momentum Factor ETF (JMOM) offers a diversified portfolio of 265 large and mid-cap U.S. stocks with a focus on ...
Data from Bloomberg as of the close of Oct. 27, 2025. Norm has an interest in some of the stocks shown.
JOET is a passively managed ETF with portfolio of 125 large-cap names sporting strong momentum & quality characteristics.
Rebel Engine achieves 72× surge in daily Steam wishlists, signaling accelerating demand and strong pre-launch traction ...
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results